IEQ Capital’s Phibro Animal Health PAHC Stock Holding History

IEQ Capital’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,358	Closed	-$302K	–	1701
2024 Q4	$302K	Buy	+14,358	New	+$332K	﹤0.01%	1024

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IEQ Capital's PAHC Position: Q1 2025 in Review

IEQ Capital sold out of Phibro Animal Health (PAHC) in Q1 2025, closing a stake of 14,358 shares — an estimated $302K sold.

IEQ Capital first reported a position in PAHC in Q4 2024 and held it in 1 quarter. The position peaked at $302K in Q4 2024. 182 funds tracked by Wall St. Rank hold PAHC as of Q1 2025.

IEQ Capital reported no remaining Phibro Animal Health position as of Q1 2025 after selling out during the quarter.
IEQ Capital sold 14,358 Phibro Animal Health shares in Q1 2025, an estimated $302K.
IEQ Capital first reported a position in Phibro Animal Health in Q4 2024 and held it in 1 quarter.
IEQ Capital's Phibro Animal Health position peaked at $302K in Q4 2024.
182 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2025.

Based on IEQ Capital's 13F filing for Q1 2025, filed 14 May 2025.